As STAT3 dysregulation contributes to many pathological situations during infectious or neoplastic diseases (55) a broader understanding of miRNAs–STAT3 interactions could help to manipulate them for developing novel therapeutic approaches. The gene discussed is STAT3; the disease is neoplasm.